1. Home
  2. Live Updates
  3. Clinformatics data mart

Page 3 - Clinformatics Data Mart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinformatics data mart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinformatics Data Mart Today - Breaking & Trending Today

Semaglutide Use Surges in US Adults With Diabetes

By the first quarter 2022, 57% of US adults with type 2 diabetes taking an incretin-based agent were taking a GLP-1 receptor agonist; DPP-4 inhibitor use fell to 39% of these scripts. ....

United States , Wegovy Novo Nordisk , Ozempic Novo Nordisk , Alexander Kutz , Dulaglutide Trulicity , Boehringer Ingelheim , Drug Administration , European Association For The Study Of Diabetes , Novo Nordisk , Elisabetta Patorno , European Association , Expand Further , Semaglutide Had , Biggest Gain , Clinformatics Data Mart ,

Real-World Data Highlight Benefits of Thymectomy in Patients With NTMG

However, few patients with nonthymomatous myasthenia gravis (NTMG) undergo this procedure, results suggest. ....

Myasthenia Gravis Foundation Of America , Myasthenia Gravis Foundation , Clinformatics Data Mart , Claims Database ,

Low Co-Pays Drive Better Adherence to New Diabetes Drugs

Low co-pays linked with substantially better 12-month adherence to expensive SGLT2 inhibitors and GLP-1 agonists among US patients with type 2 diabetes or heart failure. ....

United States , Utiber Essien , Balvindar Singh , University Of Pittsburgh , Clinformatics Data Mart ,

High Out-of-Pocket Costs Linked to Lower Likelihood of SGLT2i, GLP-1 RA Initiation

Among more than 80,000 older adults with T2D and established CVD, those in the highest quartile of out-of-pocket costs were less likely to initiate a GLP-1 R or SGLT2 inhibitor. ....

Linkedin Jing Luo , Jing Luo , University Of Pittsburgh School Medicine , Pittsburgh School , Clinformatics Data Mart ,

Real-World Data on COPD Combo Inhalers Favor LAMA-LABAs

Reduced exacerbations, pneumonia hospitalizations seen versus ICS-LABAs in observational study ....

United States , William Feldman , Global Initiative For Chronic Obstructive Lung Disease , Global Initiative , Chronic Obstructive Lung Disease , Clinformatics Data Mart ,